Preclinical and Human Phase 1 Studies of Aerosolized Hydroxychloroquine: Implications for Antiviral COVID-19 Therapy
View ORCID ProfileOhad S. Bentur, Richard Hutt, Donna Brassil, Ana C. Kriegegr, Per Bäckman, B. Lauren Charous, View ORCID ProfileHomer Boushey, Igor Gonda, View ORCID ProfileBarry S. Coller, View ORCID ProfileRobert B. MacArthur
doi: https://doi.org/10.1101/2023.06.22.23291702
Ohad S. Bentur
1Allen and Frances Adler Laboratory of Blood and Vascular Biology, Rockefeller University, New York, NY
2The Rockefeller University Hospital and Center for Clinical and Translational Science, Rockefeller University, New York, NY, USA
Richard Hutt
2The Rockefeller University Hospital and Center for Clinical and Translational Science, Rockefeller University, New York, NY, USA
Donna Brassil
2The Rockefeller University Hospital and Center for Clinical and Translational Science, Rockefeller University, New York, NY, USA
Ana C. Kriegegr
3Weill Cornell Medical College, Cornell University, New York, NY
Per Bäckman
4Emmace Consulting AB, Sweden
B. Lauren Charous
5Pulmoquine Therapeutics Inc., CA
Homer Boushey
6Department of Medicine, University of California, San Francisco, CA
Igor Gonda
7Respidex LLC, Dennis, MA
Barry S. Coller
1Allen and Frances Adler Laboratory of Blood and Vascular Biology, Rockefeller University, New York, NY
2The Rockefeller University Hospital and Center for Clinical and Translational Science, Rockefeller University, New York, NY, USA
Robert B. MacArthur
2The Rockefeller University Hospital and Center for Clinical and Translational Science, Rockefeller University, New York, NY, USA

Article usage
Posted July 01, 2023.
Preclinical and Human Phase 1 Studies of Aerosolized Hydroxychloroquine: Implications for Antiviral COVID-19 Therapy
Ohad S. Bentur, Richard Hutt, Donna Brassil, Ana C. Kriegegr, Per Bäckman, B. Lauren Charous, Homer Boushey, Igor Gonda, Barry S. Coller, Robert B. MacArthur
medRxiv 2023.06.22.23291702; doi: https://doi.org/10.1101/2023.06.22.23291702
Preclinical and Human Phase 1 Studies of Aerosolized Hydroxychloroquine: Implications for Antiviral COVID-19 Therapy
Ohad S. Bentur, Richard Hutt, Donna Brassil, Ana C. Kriegegr, Per Bäckman, B. Lauren Charous, Homer Boushey, Igor Gonda, Barry S. Coller, Robert B. MacArthur
medRxiv 2023.06.22.23291702; doi: https://doi.org/10.1101/2023.06.22.23291702
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)